Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17175683 | 1.00 | LMNA (0.31) | LMNA | |
| SCHEMBL14984896 | 0.92 | — | — | |
| SCHEMBL13204375 | 0.90 | LMNA (0.35) | LMNA | |
| SCHEMBL164465 | 0.90 | LMNA (0.35) | LMNA | |
| SCHEMBL4363324 | 0.90 | — | — | |
| SCHEMBL8838047 | 0.89 | — | — | |
| SCHEMBL12301875 | 0.89 | — | — | |
| SCHEMBL28867281 | 0.89 | — | — | |
| SCHEMBL23142642 | 0.87 | — | — | |
| SCHEMBL30671938 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240093058-A1 | POLYSILAZANE HARD COATING COMPOSITIONS | MERCK PATENT GMBH (DE) | 2024-03-21 | — | — | US | claimed |
| EP-4274866-A1 | POLYSILAZANE HARD COATING COMPOSITIONS | Merck Patent GmbH (DE) | 2023-11-15 | — | — | EP | claimed |
| WO-2022148757-A1 | POLYSILAZANE HARD COATING COMPOSITIONS | MERCK PATENT GMBH (DE) | 2022-07-14 | — | — | WO | claimed |
| US-8703866-B2 | Room temperature curable organopolysiloxane composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-04-22 | — | — | US | claimed |
| WO-2026105567-A1 | BRANCHED ORGANOPOLYSILOXANE, CURABLE COMPOSITION, AND USE THEREOF | ダウ・東レ株式会社 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026105566-A1 | BRANCHED ORGANOPOLYSILOXANE, CURABLE COMPOSITION, AND USE THEREOF | ダウ・東レ株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-20260098128-A1 | CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF | DOW TORAY CO LTD (JP) | 2026-04-09 | — | — | US | disclosed |
| US-12583975-B2 | UV-curable organopolysiloxane composition and use thereof | DOW TORAY CO., LTD. (JP) | 2026-03-24 | — | — | US | disclosed |
| US-20260062519-A1 | CURABLE SILICONE COMPOSITION, CURED PRODUCT THEREOF, LAYERED BODY, AND OPTICAL DEVICE OR OPTICAL DISPLAY | DOW TORAY CO LTD (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260050218-A1 | PHENOLIC HYDROXYL GROUP-CONTAINING BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF | DOW TORAY CO LTD (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20260049187-A1 | CO-MODIFIED BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME | DOW TORAY CO LTD (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20260022270-A1 | CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME | DOW TORAY CO LTD (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20210062040-A1 | POLYSILAZANE COMPOSITION, COATED SUBSTRATE, AND MULTILAYER CONSTRUCTION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| US-10590219-B2 | Retardation material-forming resin composition, orientation material, and retardation material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| US-20180355087-A1 | RETARDATION MATERIAL-FORMING RESIN COMPOSITION, ORIENTATION MATERIAL, AND RETARDATION MATERIAL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-12-13 | — | — | US | disclosed |
| US-10081693-B2 | Retardation material-forming resin composition, orientation material, and retardation material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-09-25 | — | — | US | disclosed |
| US-20160369025-A1 | RETARDATION MATERIAL-FORMING RESIN COMPOSITION, ORIENTATION MATERIAL, AND RETARDATION MATERIAL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-8703866-B2 | Room temperature curable organopolysiloxane composition | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-04-22 | — | — | US | disclosed |
| EP-2130873-A1 | Room temperature curable organopolysiloxane composition | Shin-Etsu Chemical Co., Ltd. (JP) | 2009-12-09 | — | — | EP | disclosed |
| US-20090286916-A1 | ROOM TEMPERATURE CURABLE ORGANOPOLYSILOXANE COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022270-A1 | CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME | PLOD3, PLOD2, PLOD1 | LMNA 1638/4885 |
| US-20260050218-A1 | PHENOLIC HYDROXYL GROUP-CONTAINING BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF | MSR1, HAO2, HAO1 | LMNA 1575/4885 |
| US-20260049187-A1 | CO-MODIFIED BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME | MSR1, HAO2, COL2A1 | LMNA 1036/4885 |
| US-20260098128-A1 | CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF | COL2A1, COL1A1, SEM1 | LMNA 1124/4885 |
| US-20260062519-A1 | CURABLE SILICONE COMPOSITION, CURED PRODUCT THEREOF, LAYERED BODY, AND OPTICAL DEVICE OR OPTICAL DISPLAY | C9, RAD51, C5 | LMNA 1216/4885 |
| US-12583975-B2 | UV-curable organopolysiloxane composition and use thereof | F12, FUCA1, XPA | LMNA 356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.